Interleukin-18 in cancer immunology and immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interleukin-18 in cancer immunology and immunotherapy

Published:2023-11-02 Issue:11 Volume:27 Page:1035-1042
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Cirella Assunta¹²,Olivera Irene¹²,Luri-Rey Carlos¹²,Bolaños Elixabet¹²,Berraondo Pedro¹²³,Melero Ignacio¹²³⁴⁵

Affiliation:

1. Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain

2. Navarra Institute for Health Research (IDISNA), Pamplona, Spain

3. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain

4. Department of Immunology and immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain

5. Department of oncology, Clínica Universidad de Navarra, Madrid, Spain

Funder

Horizon 2020

Ministry of Economy

Cancer Research Institute

Instituto de Salud Carlos III

Cancer Research UK

Fundación BBVA

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2023.2287574

Reference84 articles.

1. A guide to cancer immunotherapy: from T cell basic science to clinical practice

2. Immune checkpoint signaling and cancer immunotherapy

3. Harnessing cytokines and chemokines for cancer therapy

4. Endotoxin-induced serum factor that stimulates gamma interferon production

5. Cloning of a new cytokine that induces IFN-γ production by T cells

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing cytokines to optimize chimeric antigen receptor-T cell therapy for gastric cancer: Current advances and innovative strategies;Biomedicine & Pharmacotherapy;2024-09

2. IL-18 primes T cells with an antigen-inexperienced memory phenotype for proliferation and differentiation into effector cells through Notch signaling;Journal of Leukocyte Biology;2024-08-30

3. PTBP3 Mediates IL‐18 Exon Skipping to Promote Immune Escape in Gallbladder Cancer;Advanced Science;2024-08-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3